APA (7th ed.) Citation

Glatz, J. F., Luiken, J. J., & Nabben, M. (2020). CD36 (SR-B2) as a Target to Treat Lipid Overload-Induced Cardiac Dysfunction. The Korean Society of Lipid and Atherosclerosis.

Chicago Style (17th ed.) Citation

Glatz, Jan F.C., Joost J.F.P Luiken, and Miranda Nabben. CD36 (SR-B2) as a Target to Treat Lipid Overload-Induced Cardiac Dysfunction. The Korean Society of Lipid and Atherosclerosis, 2020.

MLA (9th ed.) Citation

Glatz, Jan F.C., et al. CD36 (SR-B2) as a Target to Treat Lipid Overload-Induced Cardiac Dysfunction. The Korean Society of Lipid and Atherosclerosis, 2020.